Overview

Pharmacokinetic Drug Interaction Between Pregabalin and Thioctic Acid.

Status:
Completed
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
A randomized, open-label, six-sequence, three-period, three-treatment, multiple dosing clinical trial to investigate the pharmacokinetic drug interaction between Pregabalin and Thioctic acid after oral administration in healthy male volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
Unimed Pharmaceuticals
Treatments:
Pregabalin
Thioctic Acid